<?xml version="1.0" encoding="UTF-8"?>
<p>There are also troubling trends among the efforts to develop a vaccine. At the time of this writing, ten vaccine candidates are undergoing evaluation in human clinical trials, while several others are in preclinical stages of investigation.
 <xref rid="eahr500060-bib-0015" ref-type="ref">
  <sup>15</sup>
 </xref> Estimated projections are that it will take 12 to 18 months to complete the typical three phases of human clinical trials. However, pregnant women are excluded from all ten vaccine trials at this time, and one trial requires participants to be on “effective” contraceptives during its entirety;
 <xref rid="eahr500060-bib-0016" ref-type="ref">
  <sup>16</sup>
 </xref> when pregnant women will be eligible to receive a vaccine is unknown. This situation is not unprecedented. Historically, pregnant women have been excluded from initial vaccine trials, leading to delays in their access to the benefits of immunization against infectious diseases that are available to others.
 <xref rid="eahr500060-bib-0017" ref-type="ref">
  <sup>17</sup>
 </xref>
</p>
